| __timestamp | Iovance Biotherapeutics, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 9335772 | 612613000000 |
| Thursday, January 1, 2015 | 12390000 | 650773000000 |
| Friday, January 1, 2016 | 25602000 | 619061000000 |
| Sunday, January 1, 2017 | 21262000 | 628106000000 |
| Monday, January 1, 2018 | 28430000 | 717599000000 |
| Tuesday, January 1, 2019 | 40849000 | 964737000000 |
| Wednesday, January 1, 2020 | 60210000 | 875663000000 |
| Friday, January 1, 2021 | 83664000 | 886361000000 |
| Saturday, January 1, 2022 | 104097000 | 997309000000 |
| Sunday, January 1, 2023 | 106916000 | 1053819000000 |
| Monday, January 1, 2024 | 1053819000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Takeda Pharmaceutical Company Limited, a global leader, and Iovance Biotherapeutics, Inc., a rising star, offer a fascinating contrast. Over the past decade, Takeda's SG&A expenses have shown a steady increase, peaking at approximately 1.05 trillion yen in 2023, reflecting its expansive global operations. In contrast, Iovance's SG&A expenses, though significantly smaller, have grown by over 1,000% since 2014, highlighting its aggressive growth strategy. This comparison underscores the diverse strategies employed by established giants and emerging innovators in managing operational costs. While Takeda's scale allows for substantial investment in administrative functions, Iovance's rapid increase signals its commitment to scaling operations. As the industry continues to evolve, these insights provide a window into the strategic priorities of pharmaceutical companies.
Amgen Inc. or Takeda Pharmaceutical Company Limited: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Teva Pharmaceutical Industries Limited Trends and Insights
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Summit Therapeutics Inc. Trends and Insights
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Neurocrine Biosciences, Inc. Trends and Insights
Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Rhythm Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited or Dynavax Technologies Corporation: Who Manages SG&A Costs Better?
Takeda Pharmaceutical Company Limited and Taro Pharmaceutical Industries Ltd.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Iovance Biotherapeutics, Inc.